Recombinant multi-species LGALS13 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis

Genemedi produces recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine LGALS13 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis.
Lysophospholipases are enzymes that act on biological membranes to regulate the multifunctional lysophospholipids. The protein encoded by this gene has lysophospholipase activity. It is composed of two identical subunits which are held together by disulfide bonds. This protein has structural similarity to several members of the beta-galactoside-binding S-type lectin family. [provided by RefSeq, Jul 2008]
The Alternative Names of target: GAL13,Galactoside-binding soluble lectin 13,Galectin-13 (Gal-13),LGALS13,PLAC8,PP13,Placental protein 13),Placental tissue protein 13 (PP13

Target products collectionGo to LGALS13 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)

pdfMSDSpdfCOApdfDatasheet

Product information

Catalog No. Product Name Species Reactivity
GM-Tg-hg-IP7794-Ag-1/ GM-Tg-hg-IP7794-Ag-2 Human LGALS13 protein Human
GM-Tg-rg-IP7794-Ag-1/ GM-Tg-rg-IP7794-Ag-2 Rat LGALS13 protein Rat
GM-Tg-mg-IP7794-Ag-1/ GM-Tg-mg-IP7794-Ag-2 Mouse LGALS13 protein Mouse
GM-Tg-cynog-IP7794-Ag-1/ GM-Tg-cynog-IP7794-Ag-2 Cynomolgus/Rhesus macaque LGALS13 protein Cynomolgus/ Rhesus macaque
GM-Tg-felg-IP7794-Ag-1/ GM-Tg-felg-IP7794-Ag-2 Feline LGALS13 protein Feline
GM-Tg-cang-IP7794-Ag-1/ GM-Tg-cang-IP7794-Ag-2 Canine LGALS13 protein Canine
GM-Tg-bovg-IP7794-Ag-1/ GM-Tg-bovg-IP7794-Ag-2 Bovine LGALS13 protein Bovine
GM-Tg-equg-IP7794-Ag-1/ GM-Tg-equg-IP7794-Ag-2 Equine LGALS13 protein Equine

Size： 1mg | 10mg | 100mg



Product Description

Catalog No. GM-Tg-hg-IP7794-Ag-1/ GM-Tg-hg-IP7794-Ag-2; GM-Tg-rg-IP7794-Ag-1/ GM-Tg-rg-IP7794-Ag-2;
GM-Tg-mg-IP7794-Ag-1/ GM-Tg-mg-IP7794-Ag-2; GM-Tg-cynog-IP7794-Ag-1/ GM-Tg-cynog-IP7794-Ag-2;
GM-Tg-felg-IP7794-Ag-1/ GM-Tg-felg-IP7794-Ag-2; GM-Tg-cang-IP7794-Ag-1/ GM-Tg-cang-IP7794-Ag-2;
GM-Tg-bovg-IP7794-Ag-1/ GM-Tg-bovg-IP7794-Ag-2; GM-Tg-equg-IP7794-Ag-1/ GM-Tg-equg-IP7794-Ag-2
Products Name LGALS13 protein
Species Human, Cynomolgus/ Rhesus macaque, rat, mouse, Feline, Canine, Bovine, Equine
Target Name LGALS13
Protein Sub-location Introcelluar Protein
Isotypes Recombinant protein
Expression platform Mammalian cell
Bioactivity validation Affintiy&bioactivity validated by ELISA, cell culture validated.
Tag His
Products description Recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine LGALS13 protein was expressed in mammalian cell expression system and is expressed with 6 HIS tag at the C-terminus for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic).
Purity Purity: ≥95% (SDS-PAGE)
Application In vitro study, in vivo study, benchmark, positive control for the diagnosis. Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference






    About Gmab

    GDU
    GDU

    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.
    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.